FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene

Mamata Singh, Justin M. Leasure, Christopher Chronowski, Brian Geier, Kathryn Bondra, Wenrui Duan, Lauren A. Hensley, Miguel Villalona-Calero, Ning Li, Anthony M. Vergis, Raushan T. Kurmasheva, Changxian Shen, Gary Woods, Nikhil Sebastian, Denise Fabian, Rita Kaplon, Sue Hammond, Kamalakannan Palanichamy, Arnab Chakravarti, Peter J. Houghton

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology